XL 413 hydrochloride
Tocris Bioscience, part of Bio-Techne | Catalog # 5493
Potent and selective Cdc7 inhibitor
Key Product Details
Description
Potent and selective Cdc7 inhibitor
Alternative Names
BMS 863233
Product Description
XL 413 hydrochloride is a potent and selective Cdc7 inhibitor (IC50 = 3.4 nM). Exhibits >12-fold selectivity for Cdc7 over PIM-1 kinase and >30-fold selectivity over pMCM and CK2. Inhibits proliferation of Colo 205 cells in vitro and attenuates tumor growth of Colo 205 xenografts in mice. XL 413 also improves homology-directed repair (HDR) editing in hematopoietic stem cells (HSC).Product Specifications
Molecular Weight
326.18
Formula
C14H12ClN3O2.HCl
Storage
Store at -20°C
Purity
≥98% (HPLC)
Chemical Name
8-Chloro-2-(2S)-2-pyrrolidinylbenzofuro[3,2-d]pyrimidin-4(3H)-one hydrochloride
CAS Number
1169562-71-3
PubChem ID
67185304
InChI Key
UNDKJUKLBNARIZ-FVGYRXGTSA-N
SMILES
ClC1=CC=C2C(C(N=[C@@]([C@H]4NCCC4)NC3=O)=C3O2)=C1.Cl
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| water | 6.52 | 20 |
Preparing Stock Solutions
for XL 413 hydrochloride
The following data is based on the product molecular weight 326.18
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.2 mM | 15.33 mL | 76.64 mL | 153.29 mL |
| 1 mM | 3.07 mL | 15.33 mL | 30.66 mL |
| 2 mM | 1.53 mL | 7.66 mL | 15.33 mL |
| 10 mM | 0.31 mL | 1.53 mL | 3.07 mL |
Calculators
Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Background References
References are publications that support the biological activity of the product.
- Koltun Discovery of XL413, a potent and selective CDC7 inhibitor. Bioorg.Med.Chem.Lett. 2012 PMID: 22560567
- Azhagiri Homology-directed gene-editing approaches for hematopoietic stem and progenitor cell gene therapy. Stem Cell Res.Ther. 2021 PMID: 34503562
- Sasi The potent Cdc7-Dbf4 (DDK) kinase inhibitor XL413 has limited activity in many cancer cell lines and discovery of potential new DDK inhibitor scaffolds. PLoS ONE 2014 PMID: 25412417
Product Specific Notices for XL 413 hydrochloride
For research use only
Loading...
Loading...